Joint HMA/EMA workshop on artificial intelligence in medicines regulation
EventHumanInnovation
Lithuanian is available via eTranslation, the European Commission's machine translation service.
Translate to Lithuanian | Important information about machine translation
Date
- Pirmadienis, 19 Balandis 2021, All day
Vieta
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
Artificial intelligence (AI) and novel digital technologies hold the promise of increasing efficiency and capacity in healthcare and of providing deeper insights from big data. The HMA-EMA Joint Big Data Task Force recommended to strengthen the network ability in AI, which is reflected in the Big Data Steering Group work plan.
The objective of this workshop is to:
- Inform on state-of-the art use of AI in medicines with keynote presentations;
- Hear the views of stakeholders and experts on the AI actions in the Big Data Taskforce and identify any gaps.
For more information, see Big data.